Fixed or variable concentrations of beta-lactamase inhibitors in in-vitro tests?

被引:9
作者
Greenwood, D [1 ]
机构
[1] UNIV NOTTINGHAM HOSP,QUEENS MED CTR,DEPT CLIN LAB SCI,PHLS LAB,NOTTINGHAM NG7 2UH,ENGLAND
关键词
D O I
10.1093/jac/38.1.17
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
[No abstract available]
引用
收藏
页码:17 / 20
页数:4
相关论文
共 21 条
[1]  
[Anonymous], M7A2 NCCLS
[2]   USE OF A PREDICTOR PANEL TO EVALUATE SUSCEPTIBILITY TESTING METHODS FOR AMPICILLIN-SULBACTAM [J].
BRADFORD, PA ;
SANDERS, CC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (02) :251-259
[3]  
COMBER KR, 1980, CLAVULANATE POTENTIA, P19
[4]  
DOLLERY C, 1994, THERAPEUTIC DRUGS S, V2, P232
[5]  
DOLLERY C, 1991, THERAPEUTIC DRUGS, pC257
[6]   COMPARATIVE INVITRO ACTIVITIES OF PIPERACILLIN-TAZOBACTAM AND TICARCILLIN-CLAVULANATE [J].
FASS, RJ ;
PRIOR, RB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (08) :1268-1274
[7]   INVITRO EVALUATION OF AUGMENTIN BY BROTH MICRODILUTION AND DISK DIFFUSION SUSCEPTIBILITY TESTING - REGRESSION-ANALYSIS, TENTATIVE INTERPRETIVE CRITERIA, AND QUALITY-CONTROL LIMITS [J].
FUCHS, PC ;
BARRY, AL ;
THORNSBERRY, C ;
GAVAN, TL ;
JONES, RN .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (01) :31-38
[9]   INVITRO EVALUATION OF CLAVULANIC ACID, A POTENT, BROAD-SPECTRUM BETA-LACTAMASE INHIBITOR [J].
GREENWOOD, D ;
OGRADY, F ;
BAKER, P .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1979, 5 (05) :539-547
[10]  
GREENWOOD D, 1993, BRIT J BIOMED SCI, V50, P31